Home : DrugWatch : Advair : News Articles

Advair - News Articles

Evaluation of suitable reference genes for gene expression studies in bronchoalveolar lavage cells from horses with inflammatory airway disease: determined by qRT-PCR in BAL samples taken pre- and post- treatment with dexamethasone and fluticasone propionate for two weeks in 7 horses with IAD. Primers'efficiencies were calculated using LinRegPCR. NormFinder, GeNorm and qBasePlus softwares were used to rank the genes according to their ...
GlaxoSmithKline updates guidelines for use of asthma drug -- , 10.1542/aapnews.20110111-4 -- AAP News: Manufacturer GlaxoSmithKline is advising physicians of updated safety information and prescribing guidelines for Serevent Diskus (salmeterol xinafoate inhalation powder) used to treat asthma. This includes patients with symptoms of nocturnal asthma. Highlights of the new safety ...
News Briefs: Week of Jan. 10-14 -- AAFP News Now -- American Academy of Family Physicians: GlaxoSmithKline is notifying physicians (11-page PDF; About PDFs) about safety information for its asthma medication salmeterol xinafoate inhalation powder, which is marketed as Serevent Diskus. The FDA announced in February 2010 that it would require new warnings for ...
The Business Matrix: Thursday 27 January 2011 - matrix, i - The Independent: A Dutch court has ruled against GlaxoSmithKline (GSK) in a patent dispute over Advair, the pharmaceutical giant's key lung therapy. ...
ÃÀ´¦·½Ò©ÁãÊÛ¼ÛÔöÕÇ8.3% Ô¶Ô¶³¬¹ýÍ¨»õÅòÕÍ-ÉúÎïÒ½Ò©²úÒµ - ÉúÎï¹È: ?????????????????,????5????:Flomax???92%;?????????Advair(salmeterol/fluticasone propionate)?Eisai?????? ...
QVAR(R) Versus Fluticasone in a Real-World Study Highlights the Importance of Inhaled Corticosteroid (ICS) Choice in Achieving Asthma Control - MarketWatch: Beacon Equity Research (blog)
had a similar or better chance of achieving asthma control as patients who were treated with fluticasone propionate (Flovent(R)). Asthma control was achieved in the QVAR population at lower doses of drug versus those in the Flovent population. ...
Hi-Tech Pharmacal Reports Sales of $40.4 Million and EPS of $0.67 for the Quarter Ended July 31, 2010 - MarketWatch: Drug Store News
Sales increases in Fluticasone Propionate nasal spray, which increased to $11700000 from $2200000, helped offset the decline in Dorzolamide product sales. Sales of cold and flu items declined in the current period, compared to a period of unusually strong demand ...
FDA warns consumers not to use stolen Advair inhalers | WOAI.COM: San Antonio News: Advair Diskus (fluticasone propionate and salmeterol inhalation powder) is an inhalerused to treat patients with asthma and chronic obstructive pulmonary disease. The products were reported stolen in August 2009 from a GlaxoSmithKline warehouse near Richmond, Va. The inhalers found ...

Side effects of Advair - by Manura Nanayakkara MBBS - Helium: Advair is an inhaled medication, prescribed in bronchial asthma and COAD (Chronic obstructive Airway disease) patients. read more Add your voice Know something about Side effects of Advair ? We want to hear your view. ...
Express.co.uk - Home of the Daily and Sunday Express | City & Business :: GlaxoSmithKline looks to enjoy a healthy future: In GSK's case of particular concern is the risk that sales of Advair, its asthma drug, will fall off due to forced relabelling – what GSK can or can't say ...
News - Symptom-Free Days More Likely With Fluticasone Furoate Therapy for Seasonal Allergic Rhinitis: Presented at EAACI: [Presentation title: Do Patients on Fluticasone Furoate (FF), Mometasone Furoate (MF) and Fluticasone Propionate (FP) Experience Similar Numbers of Symptom Free Days and Quality of Life in 3 European Countries. Abstract 380] ...
FDA Forces LABA Drugmakers to Change Labels: The change applies to LABA-only drugs such as GlaxoSmithKline's (GSK) Serevent (salmeterol xinafoate) and Novartis' Foradil (formoterol fumarate) and drug-drug combinations containing LABAs — GSK’s Advair (fluticasone propionate/salmeterol xinafoate) and AstraZeneca’s Symbicort (budenoside/formoterol fumarate dihydrate). ...
Patent protection for combination drugs in Korea - International Law Office: had an increased peak expiratory flow and a more rapid effect over the combined preparation of salmeterol (50µg) and fluticasone propionate (250µg). ...
Lexology - Other cases of interest: The label contains information about the product, including the name ADVAIR® DISKUS®, both of which are registered trade-marks. The Court concluded that GSK ...
Building on Advair - GLG News: Revolair addresses a vulnerability of GSK in the asthma and COPD market with its current product, Advair - frequency of dosage. It also prioiritizes the indication with greater unmet need: COPD. ...
Relovair expected to supplant Advair as leader in the LABA / ICS space - GLG News: GlaxoSmithKline Plc is developing its follow-on to Advair (salmeterol / fluticasone propionate) – a once daily fixed-dose combination of the inhaled corticosteroid (ICS) fluticasone furoate (685698 – currently marketed under the brand name Veramyst as an intranasal treatment for allergic ...

Do you need an Advair attorney in Washington, DC? Contact one of our Advair attorneys in Washington, DC now.

Need An Advair Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Advair Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Advair Information

Click to View Our Legal Resources

Do you need an Advair attorney in Washington, DC? Contact one of our Advair attorneys in Washington, DC now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120223-081903

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Advair Click to select a Legal Issue

Close (x)

Find Legal Help for Your Advair Case - Submit Your Information Below

Do you need legal assistance with your Advair case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Advair Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.